CurrentEndo
Get Weekly

Topic · page 17 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 641–680 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. JAMA Netw Open

    Vitamin D Receptor Polymorphisms and the Effect of Vitamin D Supplementation on Diabetes Risk Among Adults With Prediabetes

    Secondary analysis

  2. Diabetes Obes Metab

    Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA ‐ HEART

    Secondary analysis

  3. Diabetes Obes Metab

    Impact of Sodium‐Glucose Cotransporter‐2 Inhibitors on Quality of Life and Patient‐Reported Outcomes in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

    Meta-analysis

  4. Diabetes Care

    Screening for Diabetes and Prediabetes in Cystic Fibrosis Using a Nonfasting 50-Gram 1-Hour Oral Glucose Challenge Test

    Diagnostic or prognostic study

  5. Cardiovasc Diabetol

    Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study

    Cohort study

  6. BMJ Open Diabetes Res Care

    Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH

    Secondary analysis

  7. Cardiovasc Diabetol

    Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study

    Cohort study

  8. Cardiovasc Diabetol

    Phenotypic heterogeneity of type 2 diabetes and risks of complications with a tree-like representation

    Cohort study

  9. Diabetes Obes Metab

    Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP ‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

    Cohort study

  10. Diabetes Care

    Genetic Susceptibility to Diabetes Subtypes and Risk of Developing Coronary Artery Disease

    Cohort study

  11. Diabetes Res Clin Pract

    The oral–gut microbiome axis in diabetes mellitus: a systematic review and emerging clinical perspectives

    Meta-analysis

  12. Diabetes Res Clin Pract

    Trends in respiratory mortality among older U.S. adults with diabetes, 1999–2023

    Cross-sectional study

  13. Diabet Med

    Cost‐effectiveness of the diabetes remission clinical trial ( DiRECT )/Counterweight‐Plus weight management programme, based on 5‐year follow‐up

    Randomized controlled trial

  14. Cardiovasc Diabetol

    Multiblock proteomic profiling identifies novel biomarkers linking prediabetes with preclinical atherosclerosis in apparently healthy adults

    Cross-sectional study

  15. Diabetes Res Clin Pract

    Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mellitus and improve risk stratification: a prospective cohort study

    Cohort study

  16. Diabet Med

    A systematic review of the use of artificial intelligence in mental health–based diabetes care: Current applications and future directions

    Meta-analysis

  17. Diabetologia

    Post-OGTT hypoglycaemia in newly diagnosed type 2 diabetes: frequency, characteristics and cluster assignment

    Cross-sectional study

  18. Diabetes Care

    Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis

    Meta-analysis

  19. Diabetes Care

    Metabolomic Profile of Genetic Liability to Type 2 Diabetes Among 125,000 Mexican Adults: A Mendelian Randomization Study

    Diagnostic or prognostic study

  20. Endocr Pract

    Between the Guidelines: Variability in Management of Patients With Cystic Fibrosis and Dysglycemia

    Cross-sectional study

  21. J Clin Endocrinol Metab

    Patterns of TSH test after GLP-1 RAs initiation in patients on levothyroxine: a trial emulation study

    Cohort study

  22. Diabetes Obes Metab

    Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes

    Meta-analysis

  23. Cardiovasc Diabetol

    Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial

    Secondary analysis

  24. Diabetes Obes Metab

    Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes

    Cohort study

  25. Diabetes Obes Metab

    Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial

    Randomized controlled trial

  26. Cardiovasc Diabetol

    Circulating amino acids and Type 2 diabetes in a Latin American population-based cohort

    Cohort study

  27. Diabetes Obes Metab

    Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study

    Cohort study

  28. Diabetes Care

    Profiles of Social Determinants of Health and Change in Diabetes Status Among U.S. Hispanic/Latino Adults: HCHS/SOL, 2008–2024

    Cohort study

  29. Diabetes Res Clin Pract

    Association of the visceral adiposity index with prediabetes remission to normoglycemia in middle-aged and older Chinese adults: a prospective cohort study

    Cohort study

  30. Cardiovasc Diabetol

    Ancestry-specific genetics of amino acids and microbiota-related metabolites reveal causal effects on cardiometabolic disease in Chinese populations

    Cohort study

  31. Diabetes Obes Metab

    Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Type 2 Diabetes: Real‐World Evidence From the REALISED Study

    Cohort study

  32. Diabetes Obes Metab

    Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity

    Cohort study

  33. J Diabetes Sci Technol

    Development of a Calculator for HNF1A- and HNF4A-MODY in Asian Indians

    Diagnostic or prognostic study

  34. J Diabetes Sci Technol

    Real-World Follow-Up of People With Type 2 Diabetes Using a Mobile Diabetes App With Connected Glucose Meters Finds Improvements in Glycemia Are Durable Over 5 Years

    Cohort study

  35. Diabetes Res Clin Pract

    Cardiovascular-kidney-metabolic syndrome stages, stage transitions, and risk of cardiovascular disease and mortality: The Tehran Lipid and Glucose Study

    Cohort study

  36. Diabetes Technol Ther

    Continuous Glucose Monitoring Identifies Youth with Prediabetes at Risk for Glycemic Progression

    Cohort study

  37. Endocr Pract

    Effects of an Electronic Health Record Choice Architecture Intervention on Inpatient Hemoglobin A1c Testing Rates and Patient Outcomes

    Cohort study

  38. Diabetes Res Clin Pract

    Sex Differences in the Associations Between Visceral Adiposity and Hepatic Insulin Clearance in Type 2 Diabetes Mellitus: A Quantitative CT Study

    Cohort study

  39. Diabetes Res Clin Pract

    Long-term remission of impaired glucose tolerance in the finnish diabetes prevention study

    Secondary analysis

  40. Diabetes Care

    Redefining Diabetes and Creating Solutions—The Hong Kong Diabetes Register: Kelly West Award Lecture 2025

    Research article

All 4,758 Briefs in ExploreShowing Briefs 641–680 of 4,758, newest first